Who
Yi-Kuei Chen
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Apollomics.
In numbers
- Trades disclosed
- 18
- Buys
- 1
- Sells
- 0
- Bought
- $600K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jun 2026
- Last trade
- 15 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 24 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 14 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 14 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 14 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 14 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Bought | $300K20,000 at $15.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Bought | $300K20,000 at $15.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.